1
|
Ernste FC and Reed AM: Idiopathic
inflammatory myopathies: Current trends in pathogenesis, clinical
features, and up-to-date treatment recommendations. Mayo Clin Proc.
88:83–105. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Rider LG and Miller FW: Deciphering the
clinical presentations, pathogenesis, and treatment of the
idiopathic inflammatory myopathies. JAMA. 305:183–190. 2011.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Furst DE, Amato AA, Iorga ŞR, Gajria K and
Fernandes AW: Epidemiology of adult idiopathic inflammatory
myopathies in a U.S. managed care plan. Muscle Nerve. 45:676–683.
2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Oddis CV, Conte CG, Steen VD and Medsger
TA Jr: Incidence of polymyositis-dermatomyositis: A 20-year study
of hospital diagnosed cases in Allegheny County, PA 1963–1982. J
Rheumatol. 17:1329–1334. 1990.PubMed/NCBI
|
5
|
Woo JH, Kim YJ, Kim JJ, Choi CB, Sung YK,
Kim TH, Jun JB, Bae SC and Yoo DH: Mortality factors in idiopathic
inflammatory myopathy: Focusing on malignancy and interstitial lung
disease. Mod Rheumatol. 23:503–508. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Maldonado F, Patel RR, Iyer VN, Yi ES and
Ryu JH: Are respiratory complications common causes of death in
inflammatory myopathies? An autopsy study. Respirology. 17:455–460.
2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Torres C, Belmonte R, Carmona L,
Gómez-Reino FJ, Galindo M, Ramos B, Cabello A and Carreira PE:
Survival, mortality and causes of death in inflammatory myopathies.
Autoimmunity. 39:205–215. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bohan A and Peter JB: Polymyositis and
dermatomyositis (first of two parts). N Engl J Med. 292:344–347.
1975. View Article : Google Scholar : PubMed/NCBI
|
9
|
Fei Y, Shi X, Gan F, Li X, Zhang W, Li M,
Hou Y, Zhang X, Zhao Y, Zeng X and Zhang F: Death causes and
pathogens analysis of systemic lupus erythematosus during the past
26 years. Clin Rheumatol. 33:57–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Murray SG, Schmajuk G, Trupin L, Lawson E,
Cascino M, Barton J, Margaretten M, Katz PP, Yelin EH and Yazdany
J: A population-based study of infection-related hospital mortality
in patients with dermatomyositis/polymyositis. Arthritis Care Res.
67:673–680. 2015. View Article : Google Scholar
|
11
|
Martin P, Lau DT, Nguyen MH, Janssen HL,
Dieterich DT, Peters MG and Jacobson IM: A treatment algorithm for
the management of chronic hepatitis B virus infection in the United
States: 2015 update. Clin Gastroenterol Hepatol. 13:2071–2087.
2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Van Gelder H and Charles-Schoeman C: The
heart in inflammatory myopathies. Rheum Dis Clin North Am. 40:1–10.
2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Fathi M, Lundberg IE and Tornling G:
Pulmonary complications of polymyositis and dermatomyositis. Semin
Respir Crit Care Med. 28:451–458. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhang L, Wang GC, Ma L and Zu N: Cardiac
involvement in adult polymyositis or dermatomyositis: A systematic
review. Clin Cardiol. 35:686–691. 2012.PubMed/NCBI
|
15
|
Minai OA: Pulmonary hypertension in
polymyositis-dermatomyositis: Clinical and hemodynamic
characteristics and response to vasoactive therapy. Lupus.
18:1006–1010. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Couvrat-Desvergnes G, Masseau A,
Benveniste O, Bruel A, Hervier B, Mussini JM, Buob D, Hachulla E,
Rémy P, Azar R, et al: The spectrum of renal involvement in
patients with inflammatory myopathies. Medicine (Baltimore).
93:33–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Qian Y, Ren H, Chen X, Zhang W, Li X, Shi
H and Chen N: Renal injury in patients with polymyositis and
dermatomyositis. Shang Hai Jiao Tong Da Xue. 31:451–454. 2011.(In
Chinese).
|
18
|
Chen GY, Liu MF, Lee JY and Chen W:
Combination of massive mucinosis, dermatomyositis, pyoderma
gangrenosum-like ulcer, bullae and fatal intestinal vasculopathy in
a young female. Eur J Dermatol. 15:396–400. 2005.PubMed/NCBI
|
19
|
Marie I, Levesque H, Cailleux N, Courtois
H and Guédon C: Intravenous immunoglobulin for treatment of
gastro-intestinal haemorrhage in dermatomyositis. Ann Rheum Dis.
60:723–724. 2001. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tweezer-Zaks N, Ben-Horin S, Schiby G,
Bank I, Levi Y, Livneh A and Langevitz P: Severe gastrointestinal
inflammation in adult dermatomyositis: Characterization of a novel
clinical association. Am J Med Sci. 332:308–313. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang DX, Shu XM, Tian XL, Chen F, Zu N, Ma
L and Wang GC: Intravenous immunoglobulin therapy in adult patients
with polymyositis/dermatomyositis: A systematic literature review.
Clin Rheumatol. 31:801–806. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Burgin S, Stone JH, Shenoy-Bhangle AS and
McGuone D: Case records of the Massachusetts General Hospital. Case
18–2014. A 32-year-old man with a rash, myalgia, and weakness. N
Engl J Med. 370:2327–2337. 2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Brandão M and Marinho A: Idiopathic
inflammatory myopathies: Definition and management of refractory
disease. Autoimmun Rev. 10:720–724. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Carstens PO and Schmidt J: Diagnosis,
pathogenesis and treatment of myositis: Recent advances. Clin Exp
Immunol. 175:349–358. 2014. View Article : Google Scholar : PubMed/NCBI
|